An open science pathway for drug marketing authorization-Registered drug approval.

Florian Naudet and co-authors propose a pathway involving registered criteria for evaluation and approval of new drugs.

Guardado en:

Detalles Bibliográficos
Autores principales:	Florian Naudet, Maximilian Siebert, Rémy Boussageon, Ioana A Cristea, Erick H Turner
Formato:	article
Lenguaje:	EN
Publicado:	Public Library of Science (PLoS) 2021
Materias:	Medicine R
Acceso en línea:	https://doaj.org/article/6fad888a133448e59cdfcac6b785c6ac
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:6fad888a133448e59cdfcac6b785c6ac
record_format	dspace
spelling	oai:doaj.org-article:6fad888a133448e59cdfcac6b785c6ac2021-12-02T19:55:39ZAn open science pathway for drug marketing authorization-Registered drug approval.1549-12771549-167610.1371/journal.pmed.1003726https://doaj.org/article/6fad888a133448e59cdfcac6b785c6ac2021-08-01T00:00:00Zhttps://doi.org/10.1371/journal.pmed.1003726https://doaj.org/toc/1549-1277https://doaj.org/toc/1549-1676Florian Naudet and co-authors propose a pathway involving registered criteria for evaluation and approval of new drugs.Florian NaudetMaximilian SiebertRémy BoussageonIoana A CristeaErick H TurnerPublic Library of Science (PLoS)articleMedicineRENPLoS Medicine, Vol 18, Iss 8, p e1003726 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	Medicine R
spellingShingle	Medicine R Florian Naudet Maximilian Siebert Rémy Boussageon Ioana A Cristea Erick H Turner An open science pathway for drug marketing authorization-Registered drug approval.
description	Florian Naudet and co-authors propose a pathway involving registered criteria for evaluation and approval of new drugs.
format	article
author	Florian Naudet Maximilian Siebert Rémy Boussageon Ioana A Cristea Erick H Turner
author_facet	Florian Naudet Maximilian Siebert Rémy Boussageon Ioana A Cristea Erick H Turner
author_sort	Florian Naudet
title	An open science pathway for drug marketing authorization-Registered drug approval.
title_short	An open science pathway for drug marketing authorization-Registered drug approval.
title_full	An open science pathway for drug marketing authorization-Registered drug approval.
title_fullStr	An open science pathway for drug marketing authorization-Registered drug approval.
title_full_unstemmed	An open science pathway for drug marketing authorization-Registered drug approval.
title_sort	open science pathway for drug marketing authorization-registered drug approval.
publisher	Public Library of Science (PLoS)
publishDate	2021
url	https://doaj.org/article/6fad888a133448e59cdfcac6b785c6ac
work_keys_str_mv	AT floriannaudet anopensciencepathwayfordrugmarketingauthorizationregistereddrugapproval AT maximiliansiebert anopensciencepathwayfordrugmarketingauthorizationregistereddrugapproval AT remyboussageon anopensciencepathwayfordrugmarketingauthorizationregistereddrugapproval AT ioanaacristea anopensciencepathwayfordrugmarketingauthorizationregistereddrugapproval AT erickhturner anopensciencepathwayfordrugmarketingauthorizationregistereddrugapproval AT floriannaudet opensciencepathwayfordrugmarketingauthorizationregistereddrugapproval AT maximiliansiebert opensciencepathwayfordrugmarketingauthorizationregistereddrugapproval AT remyboussageon opensciencepathwayfordrugmarketingauthorizationregistereddrugapproval AT ioanaacristea opensciencepathwayfordrugmarketingauthorizationregistereddrugapproval AT erickhturner opensciencepathwayfordrugmarketingauthorizationregistereddrugapproval
_version_	1718375845951700992

An open science pathway for drug marketing authorization-Registered drug approval.

Ejemplares similares